ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Heart Transplantation for Peripartum Cardiomyopathy: Outcomes Over 3 Decades

Thursday, September 15, 2022

Submitted by

Cameron Lind

Source

Source Name: The Annals of Thoracic Surgery

Source URL: https://doi.org/10.1016/j.athoracsur.2021.12.059

Author(s)

Jennie H. Kwon, MD, Ryan J. Tedford, MD, Bhavadharini Ramu, MD, Lucas J. Witer, MD, Nicolas H. Pope, MD, Brian A. Houston, MD, Zubair A. Hashmi, MD, Marc R. Katz, MD, and Arman Kilic, MD

Over the past three decades, more than 76,000 heart transplantations have been performed. This study evaluated trends and outcomes of patients who underwent the procedure to treat peripartum cardiomyopathy (PPCM)—a disease limited to female patients—the frequency of which increased over the study period. The analysis found that the ten-, fifteen-, and twenty-year survival rates were significantly lower among PPCM heart transplant patients than other female heart transplant patients. Additionally, survival rates were even lower among Black and Hispanic patients. However, the survival rate among PPCM patients did improve over the last decade, particularly for Black transplant patients.